NAN FUNG TRINITY (HK) LTD
Position in PTGX — Protagonist Therapeutics, Inc
CIK 1781880
CENTRAL, HONG KONG, K3
Position in PTGX
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$19,694,928
+$2,760,310 QoQ
Shares Held
160,670
0.0% QoQ
Ownership
0.248%
of shares outstanding
% of Portfolio
2.20%
of 13F equity value
Holder Rank
#55
of 341 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PTGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NAN FUNG TRINITY (HK) LTD holds $246,332,678 across 20 Biotechnology names. PTGX ranks #3 (8.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MIRM |
Mirum Pharmaceuticals, Inc.
|
232,679 | $27,239,730 | |
| 2 | TRVI |
Trevi Therapeutics, Inc.
|
1,213,620 | $22,634,013 | |
| 3 | PTGX |
Protagonist Therapeutics, Inc
This page
|
160,670 | $19,694,928 | |
| 4 | ABVX |
Abivax S.A.
|
142,083 | $18,933,980 | |
| 5 | BBIO |
BridgeBio Pharma, Inc.
|
219,215 | $16,327,133 | |
| 6 | SRRK |
Scholar Rock Holding Corp
|
285,495 | $15,702,225 | |
| 7 | IMNM |
Immunome Inc.
|
714,553 | $15,141,378 | |
| 8 | XENE |
Xenon Pharmaceuticals Inc.
|
247,765 | $14,955,095 |
All Filings in PTGX
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $19,694,928 | 160,670 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $16,934,618 | 160,670 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $15,779,717 | 180,670 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $9,625,175 | 144,892 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $7,464,213 | 135,050 | Shares | Sole | 2025-08-08 | |
| No filing history on record for this holder in this stock. | ||||||